Desoximetasone

Desoximetasone (CAS No.: 382-67-2) is a synthetic corticosteroid within the glucocorticoid class that is widely used as a pharmacological tool in inflammation and immune regulation research, with primary relevance to dermatology related disease modeling and preclinical drug discovery workflows, and it is generally characterized as a glucocorticoid receptor agonist and a cytochrome P450 3A4 substrate that modulates receptor dependent transcriptional programs involved in cytokine suppression, leukocyte signaling attenuation, and regulation of cellular stress and metabolic responses, including effects on pathways commonly associated with NF kappa B and AP 1 driven inflammatory gene expression; in experimental systems, reported activity for this class is typically observed from nanomolar to micromolar concentration ranges depending on cell type, assay endpoint, and exposure duration, and when direct compound specific potency values are not uniformly available across platforms, its behavior is commonly interpreted using glucocorticoid class pharmacology as a mechanistic reference for target engagement and downstream transcriptional repression studies; accordingly, desoximetasone is frequently applied in cell based assays using keratinocytes, fibroblasts, and immune cell models, as well as in animal studies of dermatitis like inflammatory phenotypes to benchmark anti inflammatory and immunomodulatory responses, while in screening contexts it is used as a reference modulator for pathway validation, biomarker response profiling, and metabolism linked disposition assessment, with concentrations or doses used in experiments typically depending on specific experimental designs and research objectives and being restricted to controlled laboratory research use only.